Culture and characterization of human hepatocytes obtained after graft reduction for liver transplantation:: A reliable source of cells for a bioartificial liver

被引:7
|
作者
Barbich, M
Lorenti, A
Hidalgo, A
Ielpi, M
de Santibáñez, M
de Santibáñez, E
Morales, V
Marín, MC
Callero, MF
Argibay, PF
机构
[1] Hosp Italiano Buenos Aires, ICBME, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Surg, Buenos Aires, DF, Argentina
关键词
human hepatocytes; graft reduction; albumin synthesis; urea production; bioartificial liver; primary culture;
D O I
10.1111/j.1525-1594.2004.07301.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This article describes results obtained when human liver cells obtained from reduced grafts are cultured in a chemically defined medium. Remnants of livers after reduction for pediatric transplantation were processed by a multiple cannulation system through the existing vasculature, which allowed the homogeneous perfusion of collagenase. The graft weight ranged between 55 and 1000 g (median value: 145.6 g). The yield ranged between 0.13 x 10(6) and 38 x 10(6) cells/g of tissue (median value 14.73 x 10(6) cells/g), and the viability was 61.17 +/- 27.43%. The total number of cells ranged between 57.6 x 10(6) and 12 150 x 10(6) cells (median value: 740 x 10(6) cells). Cells were cultured for 30 days. Albumin synthesis was observed during the first 2 weeks, with a peak value at day 6 (27.85 +/- 1.77 mug/mL). Urea production was detected during the first week (peak value at day 6: 17.12 +/- 2.11 mg/dL). Light microscopy showed the presence of cells in a monolayer. Biliary pigments were observed at day 20. By immunohistochemistry, positive cells for albumin, for hepatocyte marker, cytokeratin 19, CD 34, CD 68, and for alpha actin for smooth muscle, were observed. Our results showed that hepatocytes obtained from reduced liver grafts are easily cultured and are able to maintain viability and functionality in vitro. This alternative source of human cells maintained under controlled culture conditions may play an important role in the development of a bioartificial liver.
引用
收藏
页码:676 / 682
页数:7
相关论文
共 50 条
  • [1] Development of a bioartificial liver device with culture of human liver-derived cells
    Fonsato, V.
    Herrera, M. B.
    Caronna, M.
    Buttiglieri, S.
    Camussi, G.
    Tetta, C.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (08): : 701 - 701
  • [2] Comparison of pig, human and rat hepatocytes as a source of liver specific metabolic functions in culture systems - implications for use in bioartificial liver devices
    Vilei, MT
    Granato, A
    Ferraresso, C
    Neri, D
    Carraro, P
    Gerunda, G
    Muraca, M
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2001, 24 (06): : 392 - 396
  • [3] First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation
    Baccarani, U
    Donini, A
    Sanna, A
    Risaliti, A
    Cariani, A
    Nardo, B
    Cavallari, A
    Martinelli, G
    Ridolfi, L
    Bellini, G
    Scalamogna, M
    Bresadola, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) : 286 - 289
  • [4] Development of a bioartificial liver device with culture of human liver-derived cells.
    Fonsato, V
    Buttiglieri, S
    Herrera, MB
    Caronna, M
    Tetta, C
    Camussi, G
    LIVER TRANSPLANTATION, 2006, 12 (05) : C42 - C42
  • [5] Establishment of hTERT-immortalized human hepatocytes as a source for a hybrid bioartificial liver.
    Totsugawa, T
    Kobayashi, N
    Noguchi, H
    Watanabe, T
    Matsumura, T
    Maruyama, M
    Matsumoto, T
    Tanaka, N
    Westerman, KA
    Leboulch, P
    HEPATOLOGY, 2001, 34 (04) : 305A - 305A
  • [6] Challenging Small Human Hepatocytes with Opiates: Further Characterization of a Novel Prototype Bioartificial Liver
    Wurm, Martin
    Woess, Claudia
    Libiseller, Kathrin
    Beer, Beate
    Pavlic, Marion
    TISSUE ENGINEERING PART A, 2010, 16 (03) : 807 - 813
  • [7] Noninvasive characterization of graft steatosis after liver transplantation
    Karlas, Thomas
    Kollmeier, Johanna
    Boehm, Stephan
    Mueller, Juergen
    Kovacs, Peter
    Troeltzsch, Michael
    Weimann, Antje
    Bartels, Michael
    Rosendahl, Jonas
    Moessner, Joachim
    Berg, Thomas
    Keim, Volker
    Wiegand, Johannes
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (02) : 224 - 232
  • [8] Liver stem cells: A potential source of hepatocytes for the treatment of human liver disease
    Faris, RA
    Konkin, T
    Halpert, G
    ARTIFICIAL ORGANS, 2001, 25 (07) : 513 - 521
  • [9] Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment - An ex vivo model of pig to human xenotransplantation
    Baquerizo, A
    Mhoyan, A
    Kearns-Jonker, A
    Arnaout, WS
    Shackleton, C
    Busuttil, RW
    Demetriou, AA
    Cramer, DV
    TRANSPLANTATION, 1999, 67 (01) : 5 - 18
  • [10] The capability of isolated hepatocytes and liver slices of donor livers to predict graft function after liver transplantation
    Olinga, P
    Maring, JK
    Merema, M
    Hof, IH
    Slooff, MJH
    Meijer, DKF
    Groothuis, GMM
    LIVER, 2000, 20 (05): : 374 - 380